Navigation Links
Solazyme Announces New Senior Vice President of Business Development
Date:10/3/2007

Troy J. Campione, Ph.D., Joins Solazyme Executive Team

SOUTH SAN FRANCISCO, Calif., Oct. 3 /PRNewswire/ -- Solazyme, a bioscience company pioneering biofuels and health/wellness products from microalgae, has named Troy J. Campione, Ph.D., to the position of senior vice president of business development.

Campione will lead the development, negotiation, and finalization of partnership agreements and contracts with major companies. These deals will help fund research and development programs leveraging Solazyme's work on biofuels and industrial chemicals.

Campione has extensive experience monetizing technology across diverse industries and geographies. Most recently he was general manager and vice president of Symyx Technologies, Inc., a company providing high throughput research and informatics technologies globally to the chemical, energy, polymer, pharmaceutical, and electronics industries. At Symyx, he was accountable for collaborative research, strategic alliances, and materials licensing. During his tenure, Campione leveraged the company's technology position to negotiate more than $400 million of new research services, products, and licensing revenues with major chemical and energy companies including ExxonMobil, Dow Chemical, BP, Ineos, Innovene, and Celanese.

"Troy's breadth of experience in developing strategic alliances along with his talent for licensing technologies will enhance our ability to develop relationships with potential partners as we commercialize our algal-based technologies," said Jonathan Wolfson, president and chief operating officer of Solazyme. "We are extremely excited to have him join our management team."

Prior to Symyx, Campione spent 15 years at ExxonMobil in business, research and development, and technology management positions in Houston, Baytown, and Baton Rouge. He led the research and development activities for advanced catalyst and process technologies as worldwide basic chemicals technology manager, delivered continued success and growth of the vinyl intermediates area as its business manager, and prioritized, championed, and secured significant chemical plant expansions for the intermediates business of Exxon Chemical.

Campione earned his Ph.D. in chemical engineering from the University of Texas at Austin and also holds M.E. and B.S degrees in Chemical Engineering from Tulane University.

About Solazyme:

Founded in 2003 and headquartered in South San Francisco, California, Solazyme is a leading biotechnology company focused on the engineering and optimization of algae for production of biofuels and health and wellness materials. For more information, please visit our website: http://www.solazyme.com.

For More Information Contact:

Jackie Kolek Ellen Snook

Peppercom Peppercom

212-931-6166 415-438-9821

jkolek@peppercom.com esnook@peppercom.com


'/>"/>
SOURCE Solazyme
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... , ... February 21, 2017 , ... ... cell therapy manufacturing facility at its headquarters laboratory in Poway, California. Based ... the experience of both in-house personnel and consultants, VetStem constructed and validated a ...
(Date:2/21/2017)... and VANCOUVER, British Columbia , ... OGXI ) today announced that apatorsen results from two randomized ... of Clinical Oncology (ASCO) 2017 Genitourinary Cancers Symposium, held February ... . Clinical data from trials in bladder and prostate ... administered in combination with standard-of-care treatments. ...
(Date:2/21/2017)... 2017   Logicalis Healthcare Solutions , the healthcare-focused ... managed services provider ( www.us.logicalis.com ), today announced a ... The new service will help hospital CIOs make the ... physicians, nurses and other clinicians immediate access to a ... will allow hospital IT staff to focus on broader ...
(Date:2/21/2017)... SAN FRANCISCO , Feb. 21, 2017   ... growing genetic information companies, today announced that members of ... and Company 37th Annual Health Care Conference on Monday, ... 1:00 p.m. Pacific in Boston, Massachusetts ... the presentation may be accessed by visiting the investors ...
Breaking Biology Technology:
(Date:2/21/2017)... 2017 Der weltweite Biobanking-Sektor wird ... einem Gespräch mit mehr als 50 Vertretern aus verschiedenen Branchen ... gilt, um diese Prognose zu realisieren. ... Zu den ... finanziellen Mittel für die Biobank, die Implementierung Zeit sparender ...
(Date:2/13/2017)... Former 9/11 Commission border counsel and Special ... Kephart of Identity Strategy Partners, LLP, today releases ... "Executive Order: Protecting the Nation From Foreign Terrorist Entry ... "As President Trump,s ,Travel Ban, Executive Order gains more ... the travel ban, it is important that our national ...
(Date:2/8/2017)... 7, 2017  Aware, Inc. (NASDAQ: AWRE ), ... financial results for its quarter and year ended December 31, ... 2016 was $3.9 million compared to $6.9 million in the ... of 2016 was $0.6 million compared to $2.6 million in ... quarter of 2016 was $0.5 million, or $0.02 per diluted ...
Breaking Biology News(10 mins):